Supplementary Figure S1 from A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma
Year: 2025
Type: supplementary-materials
Abstract: Laboratory trends during treatment
Authors: Paolo Strati, Lei Feng, Andrey Tyshevich, Darya Shavronskaya, Julia Alesse, Noel English, Elizabeth Sheehan, Nikita Syzrantsev, Alexander Nesmelov, Tony Z. Zhuang, Dai Chihara, Jason R. Westin, Sairah Ahmed, Luis E. Fayad, Jared Henderson, Kylie Dent, Elizabeth McChesney, Sattva S. Neelapu, Christopher R. Flowers
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4414747013
Cites:
Cited by:
Related to:
